Prime Business Africa
In 2025, MeCure Industries, a pharmaceutical company, spent N51.18 billion on production of its products, up by 63.83 percent when compared to the N31.24 billion reported as cost of sales in 2024.
After increasing its production cost, MeCure saw a 68.80 percent growth in topline, as revenue grew to N77.69 billion last year, surpassing the N46.02 billion generated in 2024.
Join our WhatsApp ChannelAlso, gross profit surged to N26.50 billion during the period under review, compared to the N14.78 billion achieved in the year before, representing a 79.29 percent growth.
According to MeCure’s annual report and financial statements for the year ended December 31, 2025, the company spent N4,54 billion on marketing, up by 88.75 percent, having incurred N2,40 billion in 2024.
In the same vein, administrative expenses grew by 32.05 percent last year to N5.70 billion, exceeding the N4.32 billion expended in 2024.
However, MeCure’s other income declined by 25.98 percent to N167.07 million during the period under review, below the N225.72 million notched up in 2024.
Despite the double-digit decline in other income, the pharmaceutical company’s operating profit surged to N16.42 billion in 2025, overshadowing the previous year’s N8.28 billion, reflecting a 98.34 percent increase.
Although MeCure also saw a 70.58 percent increase in finance cost, which jumped to N8.49 billion in 2025, exceeding the N4.97 billion reported in 2024.
Nevertheless, profit before tax (PBT) of MeCure grew threefold or 140.17 percent year-on-year, rising to N7.93 billion, compared to the N3.30 billion recorded the year before
Also, the company’s income tax went up by 50.89 percent, from N974.12 million in 2024 to N1.46 billion.
It was also gathered that profit after tax (PAT) was N6.46 billion last year, compared to the N2.32 billion achieved in 2024, indicating an increase of 177.52 percent.
Prime Business Africa is a business, economy and policy news platform founded in 2021 by veteran journalist and media scholar, Dr Marcel Mbamalu, after he left The Guardian as Editor.
Dr Mbamalu, who serves as Founder and Publisher, set up Prime Business Africa to deliver sharp, data-driven reporting on Nigeria’s markets, trade, investment, and governance trends for decision-makers, entrepreneurs, and policy leaders.
He also writes The Bottom Line, a backpage column for Punch Newspaper every Thursday.
Under his leadership, Prime Business Africa combines deep newsroom experience with a focus on accountability journalism, aiming to bridge information gaps between Africa’s private sector and the global economy.
